I looked into this a little and found that it doesn't quite fit the narrative that I inferred (which may not be the one you were implying) from this thread. The authors are apparently from many teams all working for the pharma company Merck & Co. and the companies press release[1] suggests that part of the value of this paper is the coordination of the entire production chain. The number of authors seems to be a consequence of the purpose of the paper, Merck & Co.'s policies on attribution for publications, and the relationship between pharma and scientific publication (which I think has something to do with patents). This doesn't seem to have anything to do with university departments.
I'm not saying that it's reasonable for a paper to list 140 authors. In fact, I find the "author contribution" statement at the end to be comically vague. But I think the story is more complicated than CV padding from people who didn't make a substantial contribution.
[1] https://www.merck.com/news/merck-scientists-publish-landmark...